This video examines a phase I/II study of ibrutinib in patients with chronic GVHD who failed corticosteroids.
Lori Styles, MD
Advertisement
Articles by Lori Styles, MD
Advertisement
Latest Updated Articles
Ibrutinib Yields Response in Patients With Chronic GVHDPublished: January 25th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
